Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDP-420 vs Telithromycin in Community Acquired Pneumonia
NCT00270517Phase 2Unknown
- Sponsor
- Enanta Pharmaceuticals
- Start
- Dec 2005
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of modithromycin in community acquired pneumonia (CAP), sponsored by Enanta Pharmaceuticals. Primary endpoint: Clinical Cure. Status: unknown.
02
Drugs
modithromycin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT00270517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00270517.